If you have been harmed by the use of Yaz or Yasmin, you may be eligible to receive compensation through a Yaz and/or a settlements lawsuit. A Yaz and Yasmin settlement lawsuit may involve many factors, including the side effects of the drugs, Bayer’s negligence in agreeing to settlements, the conflict of interest of panel members, and more. This article will cover each of these factors, as well as compensation for plaintiffs in a Yaz and Yasmin lawsuit.
Side effects of Yaz and Yasmin
The Bayer pharmaceutical company has settled nearly 12,000 side effects of Yaz and its generic equivalent, Yasmin. However, some plaintiffs say Bayer should have warned patients of the potential dangers of the drug. The drug was linked to an increased risk of blood clots and heart attacks. As a result, Bayer has set aside $1.5 billion for future settlements and legal costs. Nonetheless, many people who have suffered from serious side effects have decided to take legal action against the company.
Some people who took Yaz and subsequently developed a blood clot are seeking compensation through a Yaz and Yastrozole settlement lawsuit. These women believe that Bayer failed to adequately warn patients about the risk of stroke. The company denies this and has denied any knowledge of the warnings. Unfortunately, Yaz and Yasmin are among the most widely prescribed drugs in the United States.
Bayer’s negligence in agreeing to settlements
The pharmaceutical company Bayer agreed to settle the lawsuit claiming its products caused serious health problems in women, including pulmonary embolism and gallbladder failure. It has been cited as a negligent defendant and agreed to pay up to $24 million in damages, but has not gone above this cap. It also maintains that Yaz does not cause gallbladder problems, and it can disband the settlement fund at any time.
The company allegedly lied about the side effects of Yaz and other drugs. It did not adequately research and warn about severe risks associated with Yaz and Yasmin. These products remained in the market for years, despite causing severe health problems in women. Bayer is now facing lawsuits alleging its failure to properly warn about the risks of its drugs and agreeing to spend $20 million on new ads.
Conflicts of interest of panel members
The FDA advisory committee did not recommend pulling Yasmin and Yaz off the market, as Kessler had argued. The committee also looked into Kessler’s expert report and challenged the panel’s members’ impartiality. After reading Kessler’s report, Herndon halted the trial and appointed law professor Stephen Saltzburg to mediate.
In other words, the panel’s vote would have been invalidated if the chair had a conflict of interest. It would have been 10 votes in favor, 11 against, but not a single one against the Yaz recall. If the panel had voted for a recall, thousands of women would have benefited. If the FDA had acted on this vote, the Yaz and Yasmin lawsuit would have settled for less than half the $1.25 billion it initially paid for.
The FDA failed to issue waivers for the members of the advisory panel. The government may soon require drug companies to disclose the payment of doctors. Such payments are common and often amount to bribes. While patients may assume that their physicians are acting in their best interests, these payments could lead to a conflict of interest and ineffective products. However, the government is attempting to protect consumers by requiring drug companies to disclose their payments to doctors.
Compensation for plaintiffs in Yaz and Yasmin lawsuits
The compensation for plaintiffs in Yaz and Yasmin settlements litigation focuses on the venous blood clot injuries that resulted from the use of these birth control pills. As a result, many women have had to take out second mortgages, go without child support, or lose their jobs. If you or someone you love has been harmed by Yaz or Yasmin, you may be eligible to receive compensation from Bayer and other manufacturers of the drugs.
The company’s marketing campaign for Yaz included multi-million-dollar ads targeting women under 35. Those ads claimed that Yaz could reduce bloating and water retention. The product was marketed as a safe alternative to hormonal contraceptives, but Bayer knew that it could cause side effects. The company failed to warn patients of these risks, causing a huge backlash against the drug.